148 related articles for article (PubMed ID: 24269500)
1. Lichen secondary metabolites as DNA-interacting agents.
Plsíkova J; Stepankova J; Kasparkova J; Brabec V; Backor M; Kozurkova M
Toxicol In Vitro; 2014 Mar; 28(2):182-6. PubMed ID: 24269500
[TBL] [Abstract][Full Text] [Related]
2. Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid.
Bačkorová M; Bačkor M; Mikeš J; Jendželovský R; Fedoročko P
Toxicol In Vitro; 2011 Feb; 25(1):37-44. PubMed ID: 20837130
[TBL] [Abstract][Full Text] [Related]
3. Larvicidal activity of some secondary lichen metabolites against the mosquito Culiseta longiareolata Macquart (Diptera: Culicidae).
Cetin H; Tufan-Cetin O; Turk AO; Tay T; Candan M; Yanikoglu A; Sumbul H
Nat Prod Res; 2012; 26(4):350-5. PubMed ID: 21452097
[TBL] [Abstract][Full Text] [Related]
4. Study of DNA interactions with cyclic chalcone derivatives by spectroscopic techniques.
Štefanišinová M; Tomečková V; Kožurková M; Ostró A; Mareková M
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Oct; 81(1):666-71. PubMed ID: 21778103
[TBL] [Abstract][Full Text] [Related]
5. Lichen-derived compounds show potential for central nervous system therapeutics.
Reddy RG; Veeraval L; Maitra S; Chollet-Krugler M; Tomasi S; Dévéhat FL; Boustie J; Chakravarty S
Phytomedicine; 2016 Nov; 23(12):1527-1534. PubMed ID: 27765373
[TBL] [Abstract][Full Text] [Related]
6. Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
Goga M; Antreich SJ; Bačkor M; Weckwerth W; Lang I
Protoplasma; 2017 May; 254(3):1307-1315. PubMed ID: 27645140
[TBL] [Abstract][Full Text] [Related]
7. Lichen secondary metabolites from the cultured lichen mycobionts of Teloschistes chrysophthalmus and Ramalina celastri and their antiviral activities.
Fazio AT; Adler MT; Bertoni MD; Sepúlveda CS; Damonte EB; Maier MS
Z Naturforsch C J Biosci; 2007; 62(7-8):543-9. PubMed ID: 17913069
[TBL] [Abstract][Full Text] [Related]
8. Biological Effects of Gyrophoric Acid and Other Lichen Derived Metabolites, on Cell Proliferation, Apoptosis and Cell Signaling pathways.
Mohammadi M; Bagheri L; Badreldin A; Fatehi P; Pakzad L; Suntres Z; van Wijnen AJ
Chem Biol Interact; 2022 Jan; 351():109768. PubMed ID: 34864007
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients.
Pompilio A; Pomponio S; Di Vincenzo V; Crocetta V; Nicoletti M; Piovano M; Garbarino JA; Di Bonaventura G
Future Microbiol; 2013 Feb; 8(2):281-92. PubMed ID: 23374132
[TBL] [Abstract][Full Text] [Related]
10. Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines.
Bačkorová M; Jendželovský R; Kello M; Bačkor M; Mikeš J; Fedoročko P
Toxicol In Vitro; 2012 Apr; 26(3):462-8. PubMed ID: 22285236
[TBL] [Abstract][Full Text] [Related]
11. Anti-proliferative lichen compounds with inhibitory activity on 12(S)-HETE production in human platelets.
Bucar F; Schneider I; Ogmundsdóttir H; Ingólfsdóttir K
Phytomedicine; 2004 Nov; 11(7-8):602-6. PubMed ID: 15636173
[TBL] [Abstract][Full Text] [Related]
12. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth.
Kumar KC; Müller K
J Nat Prod; 1999 Jun; 62(6):821-3. PubMed ID: 10395495
[TBL] [Abstract][Full Text] [Related]
13. Solubilization of poorly soluble lichen metabolites for biological testing on cell lines.
Kristmundsdóttir T; Jónsdóttir E; Ogmundsdóttir HM; Ingólfsdóttir K
Eur J Pharm Sci; 2005 Apr; 24(5):539-43. PubMed ID: 15784343
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.
Janočková J; Plšíková J; Kašpárková J; Brabec V; Jendželovský R; Mikeš J; Kovaľ J; Hamuľaková S; Fedoročko P; Kuča K; Kožurková M
Eur J Pharm Sci; 2015 Aug; 76():192-202. PubMed ID: 25960253
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of lichen metabolites in vitro.
Ingólfsdóttir K; Chung GA; Skúlason VG; Gissurarson SR; Vilhelmsdóttir M
Eur J Pharm Sci; 1998 Apr; 6(2):141-4. PubMed ID: 9795033
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic properties of lichen secondary metabolites.
Ulus G
Phytother Res; 2021 Jun; 35(6):3046-3058. PubMed ID: 33587324
[TBL] [Abstract][Full Text] [Related]
17. 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.
Plsikova J; Janovec L; Koval J; Ungvarsky J; Mikes J; Jendzelovsky R; Fedorocko P; Imrich J; Kristian P; Kasparkova J; Brabec V; Kozurkova M
Eur J Med Chem; 2012 Nov; 57():283-95. PubMed ID: 23072739
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells.
Fernández-Moriano C; Divakar PK; Crespo A; Gómez-Serranillos MP
Food Chem Toxicol; 2017 Jul; 105():262-277. PubMed ID: 28450128
[TBL] [Abstract][Full Text] [Related]
19. Atranorin - An Interesting Lichen Secondary Metabolite.
Studzinska-Sroka E; Galanty A; Bylka W
Mini Rev Med Chem; 2017; 17(17):1633-1645. PubMed ID: 28443519
[TBL] [Abstract][Full Text] [Related]
20. DNA binding properties of the marine sponge pigment fascaplysin.
Hörmann A; Chaudhuri B; Fretz H
Bioorg Med Chem; 2001 Apr; 9(4):917-21. PubMed ID: 11354674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
